Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A-Reference-Cited by-同舟云学术

Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A

Published:2000-11 Issue:6 Volume:6 Page:614-618
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

Scharrer I.,Brackmann H.-H.,Sultan Y.,Abshire T.,Gazengel C.,Ragni M.,Gorina E.,Vosburgh E.,Kellermann E.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2516.2000.00432.x/fullpdf

Reference15 articles.

1. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group;Schwartz;N Engl J Med,1990

2. Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A. conclusions of a 5-year study of home therapy;Seremetis;Haemophilia,1999

3. A multicenter pharmacosurveillance study for the evaluation of the efficacy and safety of recombinant factor VIII in the treatment of patients with hemophilia A;Aygören-Pürsün;Thromb Haemost,1997

4. Lusher J Arkin S Abildgaard C Hurst D Recombinant FVIII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A-Update of safety, efficacy and inhibitor development after 7 study years Thromb Haemost 1997 162 3

5. Phase I pharmacokinetic crossover trial of recombinant FVIII and a new sucrose-formulated recombinant FVIII;Hoots;Haemophilia,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial;Thrombosis Research;2019-11

2. Efficacy and safety of Nuwiq®(human-cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures;Haemophilia;2017-10-19

3. Safety and efficacy of BAY 81‐8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme;Haemophilia;2016-03

4. Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A;Thrombosis and Haemostasis;2016-01

5. Factor VIII;Meyler's Side Effects of Drugs;2016